FDA Inspection 1122664 — Loyola Univ Medical Center
The FDA completed an inspection of Loyola Univ Medical Center on Feb 6, 2020 in Maywood, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 6, 2020
- Fiscal Year
- 2020
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Maywood, IL (United States)